Knowledge, attitude, and practice regarding pharmacovigilance among hospital pharmacists in China
Our study reveals a significant scope for enhancement in the KAP of hospital pharmacists pertaining to pharmacovigilance in China. Specifically, there is a critical need to improve the understanding of pharmacovigilance's scope and responsibilities, and fostering stronger collaborative efforts between medical institutions and MAH is imperative, particularly within targeted pharmacist groups.
Authors
- Qi Zhou (ORCID: https://orcid.org/0000-0003-2591-395X)
- Qunhong Shen
- Yinchu Cheng (ORCID: https://orcid.org/0000-0001-6084-0384)
- Fang Liu (ORCID: https://orcid.org/0000-0003-3028-5927)
- Xiaojuan Li (ORCID: https://orcid.org/0000-0002-1305-0846)
- Tingting Qiu (ORCID: https://orcid.org/0000-0001-7192-4778)
- Xiaole Zhang (ORCID: https://orcid.org/0000-0002-7185-1633)
- Song Ai-ling
Institutions
- Ford Foundation (US)
- Harvard University (US)
- Peking University (CN)
- Harvard Pilgrim Health Care (US)
- Peking University Third Hospital (CN)
- Shanghai Construction Group (China) (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Therapeutic Advances in Drug Safety
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/20420986251374963
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00